Cargando…

Expression of markers of neural stem and progenitor cells in glioblastoma multiforme in relation to tumor recurrence and overall survival

Detalles Bibliográficos
Autores principales:	Wańkowicz, Paweł, Rogińska, Dorota, Machaliński, Bogusław, Nowacki, Przemysław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069432/ https://www.ncbi.nlm.nih.gov/pubmed/32190162 http://dx.doi.org/10.5114/aoms.2020.92857

Ejemplares similares

Humoral Activity of Cord Blood-Derived Stem/Progenitor Cells: Implications for Stem Cell-Based Adjuvant Therapy of Neurodegenerative Disorders
por: Paczkowska, Edyta, et al.
Publicado: (2013)

Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS
por: Baumert, Bartłomiej, et al.
Publicado: (2020)

Effect of Bortezomib on Global Gene Expression in PC12-Derived Nerve Cells
por: Łuczkowska, Karolina, et al.
Publicado: (2020)

Complement System in Pathogenesis of AMD: Dual Player in Degeneration and Protection of Retinal Tissue
por: Kawa, Milosz P., et al.
Publicado: (2014)

Paternal Finasteride Treatment Can Influence the Testicular Transcriptome Profile of Male Offspring—Preliminary Study
por: Kolasa, Agnieszka, et al.
Publicado: (2021)

Apoptosis Evaluation in Circulating CD34+-Enriched Hematopoietic Stem and Progenitor Cells in Patients with Abnormally Increased Production of Endogenous Glucocorticoids in Course of Cushing’s Syndrome
por: Kawa, Miłosz P., et al.
Publicado: (2022)

Effects of Angiotensin-Converting Enzyme Inhibition on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke
por: Gołąb-Janowska, Monika, et al.
Publicado: (2018)

Erratum to “Effects of Angiotensin-Converting Enzyme Inhibition on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke”
por: Gołąb-Janowska, Monika, et al.
Publicado: (2020)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development
por: Łuczkowska, Karolina, et al.
Publicado: (2022)

Garcinol and Anacardic Acid, Natural Inhibitors of Histone Acetyltransferases, Inhibit Rhabdomyosarcoma Growth and Proliferation
por: Tomasiak, Patrycja, et al.
Publicado: (2023)

Risk factors for ischemic stroke in patients with non-valvular atrial fibrillation and therapeutic international normalized ratio range
por: Wańkowicz, Paweł, et al.
Publicado: (2018)

Atrial fibrillation risk factors in patients with ischemic stroke
por: Wańkowicz, Paweł, et al.
Publicado: (2019)

Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme
por: Miska, Jason, et al.
Publicado: (2015)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Molecular Mechanisms of Bortezomib Action: Novel Evidence for the miRNA–mRNA Interaction Involvement
por: Łuczkowska, Karolina, et al.
Publicado: (2020)

Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013)

Association of Glioblastoma Multiforme Stem Cell Characteristics, Differentiation, and Microglia Marker Genes with Patient Survival
por: Bien-Möller, Sandra, et al.
Publicado: (2018)

Novel design of (PEG-ylated)PAMAM-based nanoparticles for sustained delivery of BDNF to neurotoxin-injured differentiated neuroblastoma cells
por: Dąbkowska, Maria, et al.
Publicado: (2020)

Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature
por: Montemurro, Nicola, et al.
Publicado: (2020)

A genetic survival network for glioblastoma multiforme
por: Lin, Andy, et al.
Publicado: (2011)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme
por: Lubanska, Dorota, et al.
Publicado: (2017)

Comparative Analysis of Global Gene Expression and Complement Components Levels in Umbilical Cord Blood from Preterm and Term Neonates: Implications for Significant Downregulation of Immune Response Pathways related to Prematurity
por: Gródecka-Szwajkiewicz, Dorota, et al.
Publicado: (2020)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Preclinical Evaluation of Long-Term Neuroprotective Effects of BDNF-Engineered Mesenchymal Stromal Cells as Intravitreal Therapy for Chronic Retinal Degeneration in Rd6 Mutant Mice
por: Lejkowska, Renata, et al.
Publicado: (2019)

Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo
por: Dąbkowska, Maria, et al.
Publicado: (2019)

Transcriptome Profile of Human Fibroblasts in an Ex Vivo Culture
por: Machaliński, Bogusław, et al.
Publicado: (2020)

Protein Arginine Methyltransferase (PRMT) Inhibitors—AMI-1 and SAH Are Effective in Attenuating Rhabdomyosarcoma Growth and Proliferation in Cell Cultures
por: Janisiak, Joanna, et al.
Publicado: (2021)

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003)

MRI Manifestions Correlate with Survival of Glioblastoma Multiforme Patients
por: Li, Wen-bin, et al.
Publicado: (2012)

High metallothionein predicts poor survival in glioblastoma multiforme
por: Mehrian-Shai, Ruty, et al.
Publicado: (2015)

Immune phenotypes predict survival in patients with glioblastoma multiforme
por: Mostafa, Haouraa, et al.
Publicado: (2016)

Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients
por: Sobuś, Anna, et al.
Publicado: (2021)

Cancer Stem Cells in Glioblastoma Multiforme
por: Bradshaw, Amy, et al.
Publicado: (2016)

BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
por: Reithmeier, Thomas, et al.
Publicado: (2010)

Different molecular patterns in glioblastoma multiforme subtypes upon recurrence
por: Martinez, Ramon, et al.
Publicado: (2009)

Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics
por: Li, Rui, et al.
Publicado: (2015)

Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
por: Zhang, Hong-Hong, et al.
Publicado: (2022)

Neuronatin in a Subset of Glioblastoma Multiforme Tumor Progenitor Cells Is Associated with Increased Cell Proliferation and Shorter Patient Survival
por: Xu, David S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hqn0r91njral38sev4hnsa3id7